Provided by Tiger Fintech (Singapore) Pte. Ltd.

Galmed Pharmaceuticals

2.51
+0.01000.40%
Post-market: 2.27-0.2400-9.56%19:51 EDT
Volume:695.10K
Turnover:1.63M
Market Cap:4.16M
PE:-0.22
High:2.54
Open:2.49
Low:2.15
Close:2.50
Loading ...
Jul 12, 2023

Correspondence

Form CORRESP - Correspondence
Jul 12, 2023

Correspondence

Form CORRESP - Correspondence
Jun 28, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jun 28, 2023

[Amend]Public Prospectus

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
Jun 17, 2023

Public Prospectus

Form F-1 - Registration statement for certain foreign private issuers
Mar 29, 2023

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 02, 2022

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 11, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 27, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
May 13, 2021

important event

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Apr 01, 2021

Correspondence

CORRESP [Cover] - Correspondence
Mar 18, 2021

Annual Report

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Mar 18, 2021

important event

6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]